Literature DB >> 17325963

Hemostatic changes in thyroid diseases: haemostasis and thrombosis.

Massimo Franchini1.   

Abstract

Several studies have reported hemostatic abnormalities, both in terms of bleeding or thrombosis, in patients with various thyroid dysfunctions. The aim of this review is to briefly discuss the relationship between thyroid disorders and hemostasis (i.e. primary hemostasis, coagulation factors and fibrinolytic system). From the analysis of the more recent literature data, it appears evident that most of the coagulation abnormalities associated with thyroid disorders are a consequence of a direct action of thyroid hormones on the synthesis of various hemostatic factors or a derangement of immune function. On the whole, these data suggest that a hypercoagulable state is present in hyperthyroid patients, while patients suffering from moderate hypothyroidism are at increased risk of thrombosis contrasting with the bleeding tendency of those presenting severe hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17325963     DOI: 10.1080/10245330600667591

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  14 in total

1.  Major Haemorrhage during Vitamin K Antagonist Treatment: The Influence of Thyroid Hormone Levels.

Authors:  Jan Debeij; Suzanne C Cannegieter; Bregje van Zaane; Anton P van Zanten; Frits R Rosendaal; Victor E A Gerdes; Pieter H Reitsma; Olaf M Dekkers
Journal:  Eur Thyroid J       Date:  2014-02-28

2.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

3.  Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2008-09-12       Impact factor: 2.300

4.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 5.  Coagulation and fibrinolysis in thyroid dysfunction.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

6.  Concurrent cranial mediastinal Blastomyces granuloma and carcinoma with cranial vena caval syndrome in a dog.

Authors:  Natashia A Evans; Katrina R Viviano
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

7.  Cerebral venous sinus thrombosis precipitated by Graves' disease.

Authors:  Abdul Rehman; Muhammad Ghazanfar Husnain; Kamran Mushtaq; Mohsen Saleh Eledrisi
Journal:  BMJ Case Rep       Date:  2018-06-04

8.  Procoagulant and anticoagulant factors in childhood hypothyroidism.

Authors:  Nevin Kilic; Yildiz Dallar; Enver Simsek; Sirma Karamercan; Ayse Esra Tapci; Bulent Alioglu
Journal:  Int J Endocrinol       Date:  2012-07-03       Impact factor: 3.257

9.  Comparative analysis of protein-protein interactions in cancer-associated genes.

Authors:  Purnima Guda; Sridar V Chittur; Chittibabu Guda
Journal:  Genomics Proteomics Bioinformatics       Date:  2009-06       Impact factor: 7.691

10.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.

Authors:  Bülent Alioğlu; Nevin Kılıç; Enver Şimşek; Yıldız Dallar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.